New York Foundation Strives To Call Attention To Diseases Of The Third World

As different as the developed world is from the developing world, so, too, are the diseases that plague their people. In industrialized countries, AIDS, cancer, and heart disease are prevalent; while in Africa, Asia, and South America, more than 700 million people suffer from one of three widespread tropical diseases: schistosomiasis, onchocerciasis, and trachoma. For the last 16 years, the Edna McConnell Clark Foundation, based in New York City, has done its part to help eradicate these deadl

Written byAngela Martello
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

As different as the developed world is from the developing world, so, too, are the diseases that plague their people. In industrialized countries, AIDS, cancer, and heart disease are prevalent; while in Africa, Asia, and South America, more than 700 million people suffer from one of three widespread tropical diseases: schistosomiasis, onchocerciasis, and trachoma.

For the last 16 years, the Edna McConnell Clark Foundation, based in New York City, has done its part to help eradicate these deadly diseases by supporting researchers investigating them, through its Program for Tropical Disease Research. "These diseases aren't getting their share of attention," says Joseph A. Cook, director of the program. "The foundation initiated this program with the intent of drawing the interest of the scientific community to these horrendous diseases."

Edna McConnell Clark and her husband, Van Alan Clark, established the foundation in 1950 primarily to help the poor. The husband-and-wife philanthropists began ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies